163 related articles for article (PubMed ID: 26348072)
1. Pharmacological caspase inhibitors: research towards therapeutic perspectives.
Kudelova J; Fleischmannova J; Adamova E; Matalova E
J Physiol Pharmacol; 2015 Aug; 66(4):473-82. PubMed ID: 26348072
[TBL] [Abstract][Full Text] [Related]
2. Targeting caspases in cancer therapeutics.
Hensley P; Mishra M; Kyprianou N
Biol Chem; 2013 Jul; 394(7):831-43. PubMed ID: 23509217
[TBL] [Abstract][Full Text] [Related]
3. The Role of Caspase Family in Acute Brain Injury: The Potential Therapeutic Targets in the Future.
Zhang A; Zhang Z; Liu Y; Lenahan C; Xu H; Jiang J; Yuan L; Wang L; Xu Y; Chen S; Fang Y; Zhang J
Curr Neuropharmacol; 2022; 20(6):1194-1211. PubMed ID: 34766893
[TBL] [Abstract][Full Text] [Related]
4. Caspase-mediated regulation of the distinct signaling pathways and mechanisms in neuronal survival.
Khan H; Bangar A; Grewal AK; Bansal P; Singh TG
Int Immunopharmacol; 2022 Sep; 110():108951. PubMed ID: 35717837
[TBL] [Abstract][Full Text] [Related]
5. A long way to go: caspase inhibitors in clinical use.
Dhani S; Zhao Y; Zhivotovsky B
Cell Death Dis; 2021 Oct; 12(10):949. PubMed ID: 34654807
[TBL] [Abstract][Full Text] [Related]
6. Variation of the aryl substituent on the piperazine ring within the 4-(piperazin-1-yl)-2,6-di(pyrrolidin-1-yl)pyrimidine scaffold unveils potent, non-competitive inhibitors of the inflammatory caspases.
Kent CR; Bryja M; Gustafson HA; Kawarski MY; Lenti G; Pierce EN; Knopp RC; Ceja V; Pati B; Walters DE; Karver CE
Bioorg Med Chem Lett; 2016 Nov; 26(22):5476-5480. PubMed ID: 27777011
[TBL] [Abstract][Full Text] [Related]
7. Small Molecule Active Site Directed Tools for Studying Human Caspases.
Poreba M; Szalek A; Kasperkiewicz P; Rut W; Salvesen GS; Drag M
Chem Rev; 2015 Nov; 115(22):12546-629. PubMed ID: 26551511
[TBL] [Abstract][Full Text] [Related]
8. Isoliquiritigenin induces caspase-dependent apoptosis via downregulation of HPV16 E6 expression in cervical cancer Ca Ski cells.
Hirchaud F; Hermetet F; Ablise M; Fauconnet S; Vuitton DA; Prétet JL; Mougin C
Planta Med; 2013 Nov; 79(17):1628-35. PubMed ID: 24214831
[TBL] [Abstract][Full Text] [Related]
9. [Caspase inhibition: From cellular biology and thanatology to potential clinical agents].
Jacotot É
Med Sci (Paris); 2020 Dec; 36(12):1143-1154. PubMed ID: 33296631
[TBL] [Abstract][Full Text] [Related]
10. Osteogenic impact of pro-apoptotic caspase inhibitors in MC3T3-E1 cells.
Kratochvílová A; Veselá B; Ledvina V; Švandová E; Klepárník K; Dadáková K; Beneš P; Matalová E
Sci Rep; 2020 May; 10(1):7489. PubMed ID: 32366890
[TBL] [Abstract][Full Text] [Related]
11. Selective detection and inhibition of active caspase-3 in cells with optimized peptides.
Vickers CJ; González-Páez GE; Wolan DW
J Am Chem Soc; 2013 Aug; 135(34):12869-76. PubMed ID: 23915420
[TBL] [Abstract][Full Text] [Related]
12. Role of caspases on cell death, inflammation, and cell cycle in glycerol-induced acute renal failure.
Homsi E; Janino P; de Faria JB
Kidney Int; 2006 Apr; 69(8):1385-92. PubMed ID: 16557226
[TBL] [Abstract][Full Text] [Related]
13. Targeting inflammatory diseases via apoptotic mechanisms.
Murphy FJ; Hayes I; Cotter TG
Curr Opin Pharmacol; 2003 Aug; 3(4):412-9. PubMed ID: 12901951
[TBL] [Abstract][Full Text] [Related]
14. Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma.
Seki K; Yoshikawa H; Shiiki K; Hamada Y; Akamatsu N; Tasaka K
Cancer Chemother Pharmacol; 2000; 45(3):199-206. PubMed ID: 10663637
[TBL] [Abstract][Full Text] [Related]
15. Caspase-3 as a therapeutic target for heart failure.
Yang B; Ye D; Wang Y
Expert Opin Ther Targets; 2013 Mar; 17(3):255-63. PubMed ID: 23294432
[TBL] [Abstract][Full Text] [Related]
16. Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release.
Zhang Y; Bhavnani BR
BMC Neurosci; 2005 Feb; 6():13. PubMed ID: 15730564
[TBL] [Abstract][Full Text] [Related]
17. Controlled Inhibition of Apoptosis by Photoactivatable Caspase Inhibitors.
Chakrabarty S; Verhelst SHL
Cell Chem Biol; 2020 Nov; 27(11):1434-1440.e10. PubMed ID: 32814013
[TBL] [Abstract][Full Text] [Related]
18. Caspase inhibitors: a review of recently patented compounds (2013-2015).
Lee H; Shin EA; Lee JH; Ahn D; Kim CG; Kim JH; Kim SH
Expert Opin Ther Pat; 2018 Jan; 28(1):47-59. PubMed ID: 28885866
[TBL] [Abstract][Full Text] [Related]
19. Stroke, myocardial infarction, acute and chronic inflammatory diseases: caspases and other apoptotic molecules as targets for drug development.
Kreuter M; Langer C; Kerkhoff C; Reddanna P; Kania AL; Maddika S; Chlichlia K; Bui TN; Los M
Arch Immunol Ther Exp (Warsz); 2004; 52(3):141-55. PubMed ID: 15247881
[TBL] [Abstract][Full Text] [Related]
20. Identification of FDA-approved drugs as novel allosteric inhibitors of human executioner caspases.
Krishna Deepak RNV; Abdullah A; Talwar P; Fan H; Ravanan P
Proteins; 2018 Nov; 86(11):1202-1210. PubMed ID: 30194780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
